Feb 2 (Reuters) - Sanofi has breached the UK pharma code of practice with unsubstantiated claims that its Beyfortus was more ...

Angitia Biopharmaceuticals has unveiled its second mega-round in 14 months, revealing a $130 million series D financing that positions the biotech to take three bone disease prospects deeper into the ...

Shares have mostly gained in Asia, although markets in Japan were dragged lower by selling of tech-related stocks. Gold and ...

HONG KONG (AP) — Asia shares were mixed on Wednesday following Wall Street losses weighed down by technology stocks, while ...

The pharma Super Bowl ads range from straightforward product promotion to raising general disease awareness, as well as serious messaging compared to a more lighthanded approach.

LONDON, Feb. 5, 2026 /PRNewswire/ -- BioPhorum, the pharmaceutical industry's most trusted collaborative network for change, today announces the formation of its inaugural Strategic Advisory Board.

By Michael Erman and Mrinalika Roy Feb 3 (Reuters) - Pfizer on Tuesday released trial data on a high-profile obesity drug ...

Eli Lilly and Novo Nordisk may want to enjoy their duopoly while they can.

Pfizer (NYSE:PFE) executives used the company’s fourth-quarter 2025 earnings call to highlight outperformance versus internal ...

Feb 3 (Reuters) - Pfizer said on Tuesday its experimental obesity drug, which it acquired through the Metsera deal, showed up ...

Feb 3(Reuters) - Pfizer on Tuesday reported fourth-quarter profit above Wall Street estimates, as sustained demand for older ...